Stock Report

All about this stock under one free report Last Updated: 19-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Onesource Specialty Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ONESOURCE | BSE: 544292

₹1,407.80

up-down-arrow ₹-25.40 (-1.77%)

As on 16-Oct-2026IST

Market cap

info icon

₹16,154 Cr

Revenue (TTM)

info icon

₹1,543 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

2.8

Div. Yield

info icon

0 %

Edit peer-selector-edit
Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Market cap (₹ Cr)
 16,154 31,674 26,307 26,224 25,017
Revenue (₹ Cr)
 1,543 3,564 9,205 1,462 1,936
Net Profit (₹ Cr)
 -48.62 414.00 -371.81 387.35 288.22
Net Margin (%)
 -3.12 11.23 -3.93 26.01 14.79
RoE (%)
 -0.61 8.38 -3.85 25.18 29.77
Price to Earnings
 -- 77.44 -- 67.90 86.80
Price-To-Book
 2.76 6.29 3.29 15.20 18.64

Income Statement (₹ Cr)

Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Operating Revenue arrow
1,543.34 3,564.00 9,205.28 1,461.80 1,935.80
Total Income arrow
1,556.90 3,686.00 9,449.59 1,489.25 1,948.58
Total Expenditure arrow
1,204.26 2,792.00 8,195.15 919.25 1,485.56
EBITDA arrow
339.09 772.00 1,010.13 542.56 450.24
Depreciation arrow
283.04 226.00 857.51 37.68 50.83
EBIT arrow
56.05 546.00 152.62 504.88 399.41
Interest arrow
125.52 217.00 342.73 3.77 40.84
Other Income arrow
13.56 122.00 244.31 27.45 12.78
Exceptional Items arrow
-11.36 12.00 -216.88 0.00 0.00
Profit before Tax arrow
-67.27 463.00 -162.68 528.56 371.35
Provision for Tax arrow
-18.65 49.00 209.13 141.21 83.14
Profit after Tax arrow
-48.62 414.00 -371.81 387.35 288.22

Liabilities (₹ Cr)

Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Shareholder's Funds arrow
5,831.29 4,940.00 8,162.62 1,653.56 1,288.82
Minority Interest arrow
0.00 -5.00 0.00 -1.13 0.00
Non-Current Liabilities arrow
936.76 1,712.00 5,044.14 42.40 202.03
Current Liabilities arrow
1,441.97 1,622.00 4,758.28 230.82 835.87
Total Liabilities arrow
8,222.05 8,578.00 17,723.32 1,983.96 2,326.71

Assets (₹ Cr)

Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Non-Current Assets arrow
6,358.46 5,343.00 10,211.52 1,026.85 519.60
Current Assets arrow
1,425.94 2,606.00 7,191.66 881.27 1,681.81
Total Assets arrow
8,222.05 8,578.00 17,723.32 1,983.96 2,326.71
Total Debt* arrow
1,276.30 2,125.00 5,495.48 26.49 259.37
Net Current Assets arrow
-16.03 984.00 2,433.38 650.46 845.94
Contingent Liabilities arrow
1,287.25 768.26 95.72 17.25 19.09

Cashflow (₹ Cr)

Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Cash From Operating Activities arrow
8.52 390.00 1,652.60 292.17 205.05
Cash Flow from Investing Activities arrow
-494.98 -241.00 -826.03 -265.94 -409.72
Cash from Financing Activities arrow
359.44 -54.00 -38.98 4.10 283.07
Net Cash Inflow / Outflow arrow
-127.02 95.00 787.59 30.33 78.39

Ratios

Profitability Ratios

 Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
ROCE (%) arrow
0.44 6.79 1.24 32.42 29.22
ROE (%) arrow
-0.61 8.38 -3.85 25.18 29.77
ROA (%) arrow
-0.62 4.94 -2.21 21.93 24.77
EBIT Margin (%) arrow
3.63 15.32 1.66 34.54 20.63
Net Margin (%) arrow
-3.12 11.23 -3.93 26.01 14.79
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Revenue Growth (%) arrow
4.29 18.37 0.78 40.90 46.65
EBIT Growth (%) arrow
-74.22 252.26 -70.53 124.50 62.13
Net Profit Growth (%) arrow
-307.89 377.85 -1,383.43 104.15 89.49
EPS Growth (%) arrow
-295.04 1,001.33 -484.84 42.32 78.60
Book Value Growth (%) arrow
-0.75 13.47 0.33 26.03 144.31

Valuation Ratios

 Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Price / Earnings arrow
-447.70 79.49 -84.07 67.90 85.46
Price / Book Value arrow
2.76 6.29 3.29 15.20 18.64
Dividend Yield (%) arrow
0.00 0.00 0.00 0.08 0.10
EV/EBITDA arrow
51.10 42.92 30.14 47.97 55.37
Market Cap (₹ Cr) arrow
16,876.12 19,071.62 18,108.89 20,944.75 12,753.19

Solvency Ratios

 Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Debt to Equity arrow
0.10 0.31 0.53 0.02 0.11
Short term debt to equity ratio arrow
0.10 0.09 0.09 0.02 0.05
Current Ratio arrow
0.99 1.61 1.51 3.82 2.01
Quick Ratio arrow
0.68 1.06 0.87 2.82 1.14
Interest Coverage arrow
0.46 3.13 0.53 141.16 10.09

Operating Efficiency Ratios

 Onesource Specialty Pharma Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Debtors to sales (%) arrow
44.72 16.50 23.44 24.80 26.28
Asset Turnover arrow
0.20 0.43 0.55 0.83 1.66
Receivable days arrow
140.79 58.75 78.20 88.98 40.13
Inventory Days arrow
75.94 75.82 93.30 56.04 60.29
Payable days arrow
225.76 186.21 226.14 99.95 232.47
Cash Conversion Cycle arrow
-9.03 -51.64 -54.64 45.07 -132.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...